Boston, MA, United States of America

Mark K Schlegel

USPTO Granted Patents = 30 

 

Average Co-Inventor Count = 5.1

ph-index = 3

Forward Citations = 36(Granted Patents)


Location History:

  • Cambridge, MA (US) (2022 - 2023)
  • Boston, MA (US) (2021 - 2024)

Company Filing History:


Years Active: 2021-2025

Loading Chart...
Loading Chart...
30 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Mark K Schlegel

Introduction

Mark K Schlegel, based in Boston, MA, is a prolific inventor with an impressive portfolio comprising 21 patents. His work primarily focuses on advancements in biotechnology and therapeutic applications, reflecting a strong commitment to addressing complex healthcare challenges.

Latest Patents

Among his latest innovations, Schlegel has developed modified RNA agents designed to achieve reduced off-target effects. This invention involves double-stranded RNA (dsRNA) capable of inhibiting the expression of target genes. Notably, the antisense strand of the dsRNA molecule contains thermally destabilizing nucleotides at the seed region, along with four 2'-fluoro modifications. The sense strand incorporates a ligand for ASGPR, opening new avenues for pharmaceutical compositions aimed at treating various disease conditions. Additionally, Schlegel has also worked on hepatitis B virus (HBV) dsRNA agents, which target the HBV genome and provide methods to inhibit the expression of HBV genes, presenting new treatment possibilities for chronic hepatitis B infections.

Career Highlights

Schlegel has held positions at prominent biotech companies such as Alnylam Pharmaceuticals, Inc. and Vir Biotechnology, Inc. His extensive experience in these organizations further emphasizes his role as a leader in the development of RNA-based therapeutics.

Collaborations

Throughout his career, Mark K Schlegel has collaborated with distinguished colleagues, including James D McIninch and Adam Castoreno. These partnerships have likely fostered an environment of innovation, allowing for the exchange of ideas and knowledge that propel advancements in biotechnology.

Conclusion

Mark K Schlegel's contributions to the field of biotechnology and his multitude of patents illustrate his significant impact on medical science. His innovative work in RNA technologies plays a crucial role in developing new treatments for viral infections and beyond, marking him as a key figure in the ongoing evolution of therapeutic strategies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…